# TocILizumab in aorTitis in GCA (TILT)

> **NCT06271018** · — · RECRUITING · sponsor: **Groupe français d'étude des Maladies Inflammatoires de loeil** · enrollment: 80 (estimated)

## Conditions studied

- Aortitis
- Giant Cell Arteritis (GCA)

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT06271018
- **Lead sponsor:** Groupe français d'étude des Maladies Inflammatoires de loeil
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** RECRUITING
- **Start date:** 2024-03-27
- **Primary completion:** 2026-09-27
- **Final completion:** 2028-03-27
- **Target enrollment:** 80 (ESTIMATED)
- **Last updated:** 2024-12-20


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06271018

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06271018, "TocILizumab in aorTitis in GCA (TILT)". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT06271018. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*